Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study.

Trial Profile

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
  • Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic retinopathy; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ADVANCE-ON
  • Most Recent Events

    • 09 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jan 2014 United Kingdom Clinical Research Network reports planned end date as 1 April 2014.
    • 21 Jun 2012 United Kingdom Clinical Research Network reports accrual to date changed from 8% to 9%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top